Other approaches, such as pro- inflammatory cytokines and costimulatory ... previously a challenge for conditionally activated agents. Werewolf completed its $56 million Series A financing in ...
Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. have announced a strategic research collaboration within the field of conditionally activated ... such as cytokines and checkpoint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback